Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 4315832, 9 pages
https://doi.org/10.1155/2017/4315832
Research Article

A New Platelet-Aggregation-Inhibiting Factor Isolated from Bothrops moojeni Snake Venom

1Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil
2Instituto Nacional de Ciência e Tecnologia em Nano-Biofarmacêutica (N-Biofar), Belo Horizonte, MG, Brazil
3Instituto de Ciências Agrárias, Universidade Federal de Uberlândia, Monte Carmelo, MG, Brazil
4Instituto de Física, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil
5Instituto Federal de Educação, Ciência e Tecnologia do Triângulo Mineiro, Campus Ituiutaba, Ituiutaba, MG, Brazil
6Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil

Correspondence should be addressed to Júnia de Oliveira Costa; rb.ude.mtfi@atsocainuj and Fábio de Oliveira; rb.ufu.amaraumu@arievilof

Received 7 July 2017; Revised 12 September 2017; Accepted 24 September 2017; Published 1 November 2017

Academic Editor: Ji-Fu Wei

Copyright © 2017 Bruna Barbosa de Sousa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X.-Y. Du, D. S. Sim, W.-H. Lee, and Y. Zhang, “Blood cells as targets of snake toxins,” Blood Cells, Molecules, and Diseases, vol. 36, no. 3, pp. 414–421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. M. Kini and H. J. Evans, “Effects of snake venom proteins on blood platelets,” Toxicon, vol. 28, no. 12, pp. 1387–1422, 1990. View at Publisher · View at Google Scholar · View at Scopus
  3. F. S. Markland, “Snake venoms and the hemostatic system,” Toxicon, vol. 36, no. 12, pp. 1749–1800, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Sajevic, A. Leonardi, and I. Križaj, “Haemostatically active proteins in snake venoms,” Toxicon, vol. 57, no. 5, pp. 627–645, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. W. Fox and S. M. T. Serrano, “Timeline of key events in snake venom metalloproteinase research,” Journal of Proteomics, vol. 72, no. 2, pp. 200–209, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Gutiérrez and A. Rucavado, “Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage,” Biochimie, vol. 82, no. 9-10, pp. 841–850, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. F. S. Markland and S. Swenson, “Snake venom metalloproteinases,” Toxicon, vol. 62, pp. 3–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Marsh and V. Williams, “Practical applications of snake venom toxins in haemostasis,” Toxicon, vol. 45, no. 8, pp. 1171–1181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. J. Calvete, P. Juárez, and L. Sanz, “Snake venomics. Strategy and applications,” Journal of Mass Spectrometry, vol. 42, no. 11, pp. 1405–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. M. Moura-da-Silva, D. Butera, and I. Tanjoni, “Importance of snake venom metalloproteinases in cell biology: Effects on platelets, inflammatory and endothelial cells,” Current Pharmaceutical Design, vol. 13, no. 28, pp. 2893–2905, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Swenson and F. S. Markland Jr., “Snake venom fibrin(ogen)olytic enzymes,” Toxicon, vol. 45, no. 8, pp. 1021–1039, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. W. Fox and S. M. T. Serrano, “Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases,” Toxicon, vol. 45, no. 8, pp. 969–985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J. W. Fox and S. M. T. Serrano, “Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity,” FEBS Journal, vol. 275, no. 12, pp. 3016–3030, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Braud, C. Bon, and A. Wisner, “Snake venom proteins acting on hemostasis,” Biochimie, vol. 82, no. 9-10, pp. 851–859, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Kamiguti, “Platelets as targets of snake venom metalloproteinases,” Toxicon, vol. 45, no. 8, pp. 1041–1049, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Y. Koh and R. M. Kini, “From snake venom toxins to therapeutics—cardiovascular examples,” Toxicon, vol. 59, no. 4, pp. 497–506, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Matsui, Y. Fujimura, and K. Titani, “Snake venom proteases affecting hemostasis and thrombosis,” Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, vol. 1477, no. 1-2, pp. 146–156, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. O. H. P. Ramos and H. S. Selistre-De-Araujo, “Snake venom metalloproteases - Structure and function of catalytic and disintegrin domains,” Comp Biochem Physiol C Toxicol Pharmacol, vol. 142, no. 3-4, pp. 328–346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Calvete, C. Marcinkiewicz, D. Monleón et al., “Snake venom disintegrins: Evolution of structure and function,” Toxicon, vol. 45, no. 8, pp. 1063–1074, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at Publisher · View at Google Scholar · View at Scopus
  21. V. M. Rodrigues, A. M. Soares, R. Guerra-Sá, V. Rodrigues, M. R. M. Fontes, and J. R. Giglio, “Structural and functional characterization of neuwiedase, a nonhemorrhagic fibrin(ogen)olytic metalloprotease from Bothrops neuwiedi snake venom,” Archives of Biochemistry and Biophysics, vol. 381, no. 2, pp. 213–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Nikai, N. Mori, M. Kishida, H. Sugihara, and A. T. Tu, “Isolation and biochemical characterization of hemorrhagic toxin f from the venom of Crotalus atrox (Western Diamondback Rattlesnake),” Archives of Biochemistry and Biophysics, vol. 231, no. 2, pp. 309–319, 1984. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Gené, A. Roy, G. Rojas, J. Gutiérrez, and L. Cerdas, “Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom,” Toxicon, vol. 27, no. 8, pp. 841–848, 1989. View at Publisher · View at Google Scholar · View at Scopus
  24. L. O. Randall and J. J. Selitto, “A method for measurement of analgesic activity on inflamed tissue,” Archives Internationales de Pharmacodynamie et de Thérapie, vol. 111, no. 4, pp. 409–419, 1957. View at Google Scholar · View at Scopus
  25. M. R. De Queiroz, C. C. N. Mamede, K. C. Fonseca et al., “Rapid purification of a new P-I class metalloproteinase from Bothrops moojeni venom with antiplatelet activity,” BioMed Research International, vol. 2014, Article ID 352420, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R. K. Andrews and M. C. Berndt, “Snake venom modulators of platelet adhesion receptors and their ligands,” Toxicon, vol. 38, no. 6, pp. 775–791, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. M. R. de Queiroz, B. B. de Sousa, D. F. da Cunha Pereira et al., “The role of platelets in hemostasis and the effects of snake venom toxins on platelet function,” Toxicon, vol. 133, pp. 33–47, 2017. View at Publisher · View at Google Scholar
  28. S. M. T. Serrano, J. Kim, D. Wang et al., “The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: Role in substrate targeting,” The Journal of Biological Chemistry, vol. 281, no. 52, pp. 39746–39756, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. T. Serrano, D. Wang, J. D. Shannon, A. F. M. Pinto, R. K. Polanowska-Grabowska, and J. W. Fox, “Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation,” FEBS Journal, vol. 274, no. 14, pp. 3611–3621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. F. S. Torres, B. Rates, M. T. Gomes et al., “Bmoo FIBMP-I: A New Fibrinogenolytic Metalloproteinase from,” ISRN Toxicology, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  31. C. P. Bernardes, N. A. Santos-Filho, T. R. Costa et al., “Isolation and structural characterization of a new fibrin(ogen)olytic metalloproteinase from Bothrops moojeni snake venom,” Toxicon, vol. 51, no. 4, pp. 574–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Escalante, A. Rucavado, J. W. Fox, and J. M. Gutiérrez, “Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases,” Journal of Proteomics, vol. 74, no. 9, pp. 1781–1794, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. L.-G. Jia, X.-M. Wang, J. D. Shannon, J. B. Bjarnason, and J. W. Fox, “Function of disintegrin-like/cysteine-rich domains of atrolysin A. Inhibition of platelet aggregation by recombinant protein and peptide antagonists,” The Journal of Biological Chemistry, vol. 272, no. 20, pp. 13094–13102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. M. T. Assakura, C. A. Silva, R. Mentele, A. C. M. Camargo, and S. M. T. Serrano, “Molecular cloning and expression of structural domains of bothropasin, a P-III metalloproteinase from the venom of Bothrops jararaca,” Toxicon, vol. 41, no. 2, pp. 217–227, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. F. R. Mandelbaum, A. P. Reichel, and M. T. Assakura, “Isolation and characterization of a proteolytic enzyme from the venom of the snake Bothrops jararaca (Jararaca),” Toxicon, vol. 20, no. 6, pp. 955–972, 1982. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Fujimura, K. Oshikawa, S. Terada, and E. Kimoto, “Primary structure and autoproteolysis of brevilysin H6 from the venom of Gloydius halys brevicaudus,” The Journal of Biochemistry, vol. 128, no. 2, pp. 167–173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. E. F. Sanchez, L. M. Gabriel, S. Gontijo et al., “Structural and functional characterization of a P-III metalloproteinase , leucurolysin -B, from Bothrops leucurus venom,” Archives of Biochemistry and Biophysics, vol. 468, no. 2, pp. 193–204, 2007. View at Publisher · View at Google Scholar
  38. Z. Zhu, W. Gong, X. Zhu, M. Teng, and L. Niu, “Purification, characterization and conformational analysis of a haemorrhagin from the venom of Agkistrodon acutus,” Toxicon, vol. 35, no. 2, pp. 283–292, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. M. J. I. Paine, H. P. Desmond, R. D. G. Theakston, and J. M. Crampton, “Purification, cloning, and molecular characterization of a high molecular weight hemorrhagic metalloprotease, jararhagin, from Bothrops jararaca venom. Insights into the disintegrin gene family,” The Journal of Biological Chemistry, vol. 267, no. 32, pp. 22869–22876, 1992. View at Google Scholar · View at Scopus
  40. Y. Usami, Y. Fujimura, S. Miura et al., “A 28-kDa Protein with Disintegrin-like Structure (Jararhagin-C) Purified from Bothrops jararaca Venom Inhibits Collagen- and ADP-Induced Platelet Aggregation,” Biochemical and Biophysical Research Communications, vol. 201, no. 1, pp. 331–339, 1994. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Zang, Z. Zhu, Y. Yu et al., “Purification, partial characterization and crystallization of acucetin, a protein containing both disintegrin-like and cysteine-rich domains released by auto-proteolysis of a P-III-type metalloproteinase AaH-IV from Agkistrodon acutus venom,” Acta Crystallographica - Section D Biological Crystallography, vol. 59, no. 12, pp. 2310–2312, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Selistre-de-Araujo, M. R. Cominetti, C. H. B. Terruggi et al., “Alternagin-C, a disintegrin-like protein from the venom of Bothrops alternatus, modulates α2β1 integrin-mediated cell adhesion, migration and proliferation,” Brazilian Journal of Medical and Biological Research, vol. 38, no. 10, pp. 1505–1511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. Higuchi, M. C. Almeida, C. C. Barros et al., “Leucurogin, a new recombinant disintegrin cloned from Bothrops leucurus (white-tailed-jararaca) with potent activity upon platelet aggregation and tumor growth,” Toxicon, vol. 58, no. 1, pp. 123–129, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. I. Limam, A. Bazaa, N. Srairi-Abid et al., “Leberagin-C, A disintegrin-like/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion,” Matrix Biology, vol. 29, no. 2, pp. 117–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. R. K. Andrews, A. S. Kamiguti, O. Berlanga, M. Leduc, R. D. G. Theakston, and S. P. Watson, “The use of snake venom toxins as tools to study platelet receptors for collagen and von Willebrand factor,” Pathophysiology of Haemostasis and Thrombosis, vol. 31, no. 3-6, pp. 155–172, 2001. View at Google Scholar · View at Scopus
  46. B. S. Coller and H. R. Gralnick, “Studies on the mechanism of ristocetin induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin,” The Journal of Clinical Investigation, vol. 60, no. 2, pp. 302–312, 1977. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Jurk and B. E. Kehrel, “Platelets: Physiology and biochemistry,” Seminars in Thrombosis and Hemostasis, vol. 31, no. 4, pp. 381–392, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Navdaev, H. Subramanian, A. Petunin, K. J. Clemetson, S. Gambaryan, and U. Walter, “Echicetin coated polystyrene beads: A novel tool to investigate GPIb-specific platelet activation and aggregation,” PLoS ONE, vol. 9, no. 4, Article ID e93569, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. A. T. Nurden, D. Didry, and J. P. Rosa, “Molecular defects of platelets in Bernard-Soulier syndrome,” Blood Cells, vol. 9, no. 2, pp. 333–358, 1983. View at Google Scholar · View at Scopus
  50. Z. M. Ruggeri, “Developing basic and clinical research on von Willebrand factor and von Willebrand disease,” Thrombosis and Haemostasis, vol. 84, no. 2, pp. 147–149, 2000. View at Google Scholar · View at Scopus
  51. M. Peng, W. Lu, L. Beviglia, S. Niewiarowski, and E. P. Kirby, “Echicetin: A snake venom protein that inhibits binding of von Willebrand factor and alboaggregins to platelet glycoprotein Ib,” Blood, vol. 81, no. 9, pp. 2321–2328, 1993. View at Google Scholar · View at Scopus
  52. Y. L. Chen and I. H. Tsai, “Functional and Sequence Characterization of Agkicetin, a New Glycoprotein IB Antagonist Isolated from Agkistrodon acutus Venom,” Biochemical and Biophysical Research Communications, vol. 210, no. 2, pp. 472–477, 1995. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Fujimura, Y. Ikeda, S. Miura et al., “Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib,” Thrombosis and Haemostasis, vol. 74, no. 2, pp. 743–750, 1995. View at Google Scholar · View at Scopus
  54. T. Kawasaki, Y. Taniuchi, N. Hisanichi et al., “Tokaracetin, a new platelet antagonist that binds to platelet glycoprotein Ib and inhibits von Willebrand factor-dependent shear-induced platelet aggregation,” Biochemical Journal, vol. 308, no. 3, pp. 947–953, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. B. S. Coller, “Anti-GPIIb-IIIa drugs: current strategies and future directions,” Thrombosis and Haemostasis, vol. 86, no. 1, pp. 427–443, 2001. View at Google Scholar · View at Scopus
  56. A. S. Kamiguti, C. R. M. Hay, R. D. G. Theakston, and M. Zuzel, “Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases,” Toxicon, vol. 34, no. 6, pp. 627–642, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Hamako, T. Matsui, S. Nishida et al., “Purification and characterization of kaouthiagin, a von Willebrand factor-binding and -cleaving metalloproteinase from Naja kaouthia cobra venom,” Thrombosis and Haemostasis, vol. 80, no. 3, pp. 499–505, 1998. View at Google Scholar · View at Scopus
  58. W.-J. Wang and T.-F. Huang, “Purification and characterization of a novel metalloproteinase, acurhagin, from Agkistrodon acutus venom,” Thrombosis and Haemostasis, vol. 87, no. 4, pp. 641–650, 2002. View at Google Scholar · View at Scopus
  59. T.-F. Huang, M.-C. Chang, and C.-M. Teng, “Antiplatelet protease, kistomin, selectively cleaves human platelet glycoprotein Ib,” BBA - General Subjects, vol. 1158, no. 3, pp. 293–299, 1993. View at Publisher · View at Google Scholar · View at Scopus
  60. C. M. Ward, R. K. Andrews, A. I. Smith, and M. C. Berndt, “Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin,” Biochemistry, vol. 35, no. 15, pp. 4929–4938, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. G. Xu, H. Ulrichts, S. Vauterin et al., “How does agkicetin-C bind on platelet glycoprotein Ibα and achieve its platelet effects?” Toxicon, vol. 45, no. 5, pp. 561–570, 2005. View at Publisher · View at Google Scholar · View at Scopus